Know Cancer

or
forgot password

Prospective , Multicentric, Randomized Phase II Study, Evaluating the Role of Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue After Conventional Chemotherapy for Primary Central Nervous System in Young Patients (< 60 y)


Phase 2
18 Years
60 Years
Open (Enrolling)
Both
Primary Central Nervous System Lymphoma

Thank you

Trial Information

Prospective , Multicentric, Randomized Phase II Study, Evaluating the Role of Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue After Conventional Chemotherapy for Primary Central Nervous System in Young Patients (< 60 y)


Inclusion Criteria:



- Histopathologically or cytologically proven diagnostic of Primary CNS lymphoma

- All histological types of non-Hodgkin's lymphoma, except MALT

- Age > 18 and < 60 ans.

- Negative for HIV, HCV and HBV

- Written informed consent -

Exclusion Criteria:

- Age < 18 or > 60 ans

- Isolated intra-ocular lymphoma

- Previous history of indolent lymphoma

- Previous chemotherapy or radiotherapy for PCNSL

- Isolated CNS relapse of systemic NHL

- Previous history of cancer in the last 5 years, except basocellular carcinoma and non
invasive cervix cancer

- Renal insufficiency or creatinin clearance < 60 ml/min

- Liver enzymes > 3N.

- Platelets < 100 000/mm3 or neutrophils < 1500/mm3)

- Previous history of organ transplantation or other cause of severe immunodeficiency

- Pregnancy or active sexual women with no contraception

- Unable to follow the protocol for any reason

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

2-years progression-free survival in each arm

Outcome Time Frame:

2 years after inclusion

Safety Issue:

Yes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

CRH 07/422/H

NCT ID:

NCT00863460

Start Date:

October 2008

Completion Date:

March 2015

Related Keywords:

  • Primary Central Nervous System Lymphoma
  • Lymphoma

Name

Location